| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.22 | 3e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.084 | 0.09 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.039 | 0.4 |